☆ 4.2 Editorial Material

What are the considerations for the pharmacotherapeutic management of acute promyelocytic leukemia in children?

EXPERT OPINION ON PHARMACOTHERAPY (2022)

Get Full Text
Add to Collection

Journal

EXPERT OPINION ON PHARMACOTHERAPY
Volume 23, Issue 3, Pages 289-294

Publisher

TAYLOR & FRANCIS LTD
DOI: 10.1080/14656566.2021.2006182

Keywords

Arsenic trioxide; all-trans retinoic acid; tailored treatment; chemotherapy-free regimens; pediatric patients; long-term sequelae

Categories

Pharmacology & Pharmacy

Funding

  1. American Italian Cancer Foundation Fellowship Program
  2. Italian Foundation for Cancer Research (AIRC) [21267]
  3. Ministry of Education, Universities and Research (MIUR), Italy [2017WXR7ZT]

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.2
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available
Webinars Posters Questions Hubs Funding Journals Papers Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.